Agata T.
- Country
- Poland
- Department
- Klinika Hematologii, Transplantologii i Terapii Komórkowych
Research Overview
- Evaluation of Belantamab Monotherapy and Combination Regimens in Patients with Multiple Myeloma: Safety and Clinical Activity Assessment
- Pharmacokinetic Comparability Study of Pre- and Post-change Teclistamab in Relapsed/Refractory Multiple Myeloma Patients
- Phase 2 Study of Cemsidomide Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
Data & Insights
Has run more than one trial at 199 of 349 partner sites.
Specializations
Multiple Myeloma Treatment
This investigator specializes in treating multiple myeloma, with particular emphasis on both newly diagnosed cases and relapsed/refractory multiple myeloma. Their research encompasses various therapeutic approaches using novel drug combinations and targeted therapies.
- Novel therapeutic combinations
- Maintenance therapy strategies
- Treatment of refractory cases
Their work involves evaluating innovative treatments including monoclonal antibodies and targeted therapies for multiple myeloma patients.
Early-Stage Plasma Cell Disorders
The investigator focuses on early intervention strategies for pre-malignant plasma cell conditions, including high-risk monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
- Early disease intervention
- Risk assessment strategies
- Prevention of disease progression
Their research explores preventive approaches and treatment strategies for high-risk precursor conditions.
Post-Transplant Care
The investigator specializes in post-transplant maintenance therapy following autologous stem cell transplantation in multiple myeloma patients.
- Maintenance therapy optimization
- Long-term disease control
- Novel maintenance approaches
Their work focuses on improving outcomes for transplant recipients through innovative maintenance strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.